Dow, S&P 500, Nasdaq futures steady after record-setting session

June 30, 2026

Breaking News

Image source: Pexels

US stock futures took a breather on Tuesday after a record-setting start to the week, as investors assessed concerns around a potential oil glut and the dollar's growing strength.

Dow Jones Industrial Average futures hovered above the flat line, after the blue-chip benchmark closed above 52,000 for the first time on Monday.

Contracts on the S&P 500 and the Nasdaq 100 were also little changed after a rally in tech stocks fueled sharp gains.

Investors are heading into the last trading day of the second quarter and first half of 2026 buoyed by a Supreme Court ruling that left Federal Reserve independence intact, for now, and by the prospect of potential US-Iran peace talks in Qatar starting Tuesday.

At the same time, oil flows through the Strait of Hormuz are recovering faster than expected, prompting a shift from fears of crude shortages to warnings of a looming glut.

Oil prices continued to fall, poised for a quarterly drop with Brent futures trading below $74 a barrel and WTI futures below $71. Yahoo Finance reports.

EdgeUp

🛰️ AST SpaceMobile shares surge, gain almost $6 billion on Japan subsidy report

AST SpaceMobile, Inc. pushed higher in early trading Tuesday, gaining more market cap in one session than the total size of the Japan subsidy that sparked the run.

The satellite-to-phone stock finished Monday at $86.77, a jump of 21.44%.

Google Finance showed another 0.83% gain to $87.49 in premarket.

Nasdaq’s premarket window is from 4:00 a.m. to 9:30 a.m. Eastern.

AST closed with a market cap of $33.68 billion, according to Google Finance.

Shares jumped 21.44%, tacking on roughly $5.95 billion from the last close.

That’s about 6.4 times the $926 million Japanese subsidy pool cited, and market cap is around 36 times that figure.

The math is rough—market cap is from the close and doesn’t use a fully diluted model. TechStock² reports.

🔒 Intrusion Announces Acquisition of VigilAigent. Stock soars in pre-market

Intrusion Inc., a leader in cyberattack prevention solutions, today announced it has completed the acquisition of VigilAigent, a cybersecurity managed security service provider, from Tego Cyber Inc.

The acquisition will accelerate Intrusion's growth strategy by adding approximately $3.5 million in annual recurring revenue from a diversified base of multi-year customer contracts, an established reseller network of more than 80 partners, and an installed base of approximately 1,000 customers, extending Intrusion's commercial reach from day one. Access Newswire reports.

⚙️ Applied Materials shares surge $54 billion, buyback effect now smaller

Applied Materials heads into Tuesday with a buyback issue of its own making.

After shares jumped 10.82% Monday, each dollar left in its repurchase plan now has less impact on earnings per share.

The chip equipment stock ended at $694.64, gaining $67.80 on the day after reaching an intraday high of $708.99.

Around 14.17 million shares changed hands, which is roughly 1.7 times its 65-day average volume.

MarketWatch posted an after-hours quote of $704.01 at 7:59 p.m. EDT. TechStock² reports.

🩺 Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots. Stock rises 20% in pre-market.

Cuprina Holdings (Cayman) Limited, a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that an indirectly wholly owned subsidiary of the company, Cuprina Pte. Ltd., has received 510(k) clearance from the U.S. Food and Drug Administration for MEDIFLY Maggots, its medical-grade Lucilia cuprina larvae used in maggot debridement therapy. To the company's knowledge, MEDIFLY Maggots is the first maggot debridement product to receive U.S. FDA 510(k) clearance using the Lucilia cuprina species.

MEDIFLY Maggots is cleared for the debridement of non-healing necrotic skin and soft tissue wounds, including pressure ulcers, neuropathic foot ulcers, and non-healing traumatic or post-surgical wounds.

The prescription product consists of medical-grade fly larvae applied to a wound under the supervision of trained healthcare professionals to remove dead and infected tissue and support the body's natural healing process. Globe Newswire reports.

Top 5 Movers in Early Pre-Market

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM ET). Stock Analysis reports.

1) JEM: 707 Cayman Holdings Limited
Total gain: +194.44%

2) ABVX: ABIVAX Société Anonyme
Total gain: +35.67%

3) AVAV: AeroVironment, Inc.
Total gain: +33.68%

4) CUPR: Cuprina Holdings (Cayman) Limited
Total gain: +23.99%

5) PAVS: Paranovus Entertainment Technology Ltd.
Total gain: +23.90%

Yesterday’s Biggest Movers

The closing price of the top three market percent gainers trading near or above $3 on June 29.

(All pricing and percent gains are based on regular market trading hours from 9:30 AM to 4:00 PM ET) Stock Analysis reports.

1) HCWB: HCW Biologics Inc.
Total gain: +410.29%
The company announced that its Board of Directors has approved a 1-for-6 reverse stock split of the Company's common stock, par value $0.0001 (“Common Stock”), which will be effective at 12:01 a.m. Eastern Time on June 30, 2026. The Company's Common Stock will be traded on The Nasdaq Capital Market on a reverse split-adjusted basis beginning on June 30, 2026, under the Company's existing trading symbol “HCWB.” Globe Newswire reports.

2) UPC: Universe Pharmaceuticals INC
Total gain: +311.49%
The company announced that the company has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited (“Best Praise”), a company that holds five patents in China with potential applications in pharmaceutical development, for a total purchase price of US$10,751,000, payable in the form of 4,376,552 Class A ordinary shares of the Company. Globe Newswire reports.

3) DCOY: Decoy Therapeutics Inc.
Total gain: +73.73%
The company announced that it has entered into a securities purchase agreement with a single healthcare focused institutional investor for a private investment in public equity financing (the "PIPE"), which is expected to provide approximately $3.5 million in gross proceeds at closing, before deducting placement agent's fees and other financing expenses payable by the Company. The Company intends to use the net proceeds to advance its lead asset into clinical trials. PR Newswire reports.

Today’s Notable Earnings

(Estimate and Actual numbers represent Earnings Per Share in US Dollars)

STZ: Constellation Brands
Q1 2027
After Market Close
Estimate: 3.210
Actual: N/A

NKE: Nike
Q4 2026
After Market Close
Estimate: 0.120
Actual: N/A

PRGS: Progress Software
Q2 2026
After Market Close
Estimate: 1.420
Actual: N/A

Today’s Economic Dates

Time (ET) / Report / Period

9:00 AM - S&P Cotality Case-Shiller Home Px Index - Apr.
9:45 AM - Chicago Business Barometer - ISM-Chicago Business Survey - Chicago PMI - Jun.
10:00 AM - Conference Bd - Consumer Confidence - Jun.

Parting Thoughts

“Victory belongs to the most persevering.”

– Napoleon Bonaparte

Sourced in: Napoleon quotations — GoodReads.

Disclaimer

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference.

The information in this newsletter summarizes the latest market activity and related news and are provided for educational purposes only. Any trading symbols displayed are for illustrative purposes only and do not constitute a recommendation by TradeZero to buy, sell, or hold any investment. This material is not intended to provide investment advice or to take into account any individual’s financial condition, investment objectives, or requirements.

Investing involves risk, including the possible loss of principal.

There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses.

Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

Stocks experiencing significant price volatility may involve substantial risk. Past performance is no guarantee of future results.

Any trading strategies discussed are for educational purposes only and should not be construed as investment advice or a recommendation.

Certain information herein has been obtained from third-party sources believed to be reliable; however, its accuracy or completeness cannot be guaranteed. The views and opinions expressed are those of the author and do not necessarily reflect the views or opinions of TradeZero, its affiliates, or employees.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.